FDA Inspection 864847 — Hikma Pharmaceuticals USA, Inc.

Hikma Pharmaceuticals USA, Inc. — FEI 2250102

The FDA completed an inspection of Hikma Pharmaceuticals USA, Inc. on Feb 26, 2014 in Eatontown, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 26, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Eatontown, NJ (United States)

Citations

IDCFRDescription
202821 CFR 211.192Extent of discrepancy, failure investigations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.